Sequella, Inc.

The United States of America, as Represented by the Secretary, Department of Health and Human Services

Other

Marina Nikolaevna Protopopova

Elena Bogatcheva

Richard Edward Lee

Clifton E Barry, Iii

Richard Allan Slayden

Leo Einck

Christopher Joseph Welch

Boris Nikonenko

Bhat Ganapati

Clifton E Barry

Clifton E Barry Iii

Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis.

Compositions and methods for the treatment of infectious diseases

Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis.

Methods of use and compositions for the diagnosis and treatment of infectious diseases

Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising novel diamine compositions for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis.

Methods and compositions comprising diamines as new anti-tubercular therapeutics

Anti tubercular drug: compositions and methods

Methods of use and compositions for the diagnosis and treatment of infectious disease

Methods and compositions for treating disease caused by microorganisms, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis.

The invention discloses a method for rapid identification of a candidate selective separation material by placing small samples of the candidate material in an array of vials and adding a solution of the analytes to be separated. The solution is allowed to interact or equilibrate and the distribution of the analytes in the solid or liquid phase is measured usually by gas or liquid chromatography. The identified candidate material with the greatest differential adsorption of the analytes is selected and used as an adsorbent for large scale separation. The rapid screening of chromatographic adsorbents provides an efficient way of finding suitable absorbent materials for large scale separations.

Method for screening chromatographic adsorbents

Growing community of inventors

Silver Spring, MD, United States of America

Marina Nikolaevna Protopopova